BIOLARGO, INC. logo

BIOLARGO, INC.

BLGO
Last price US$0.11
Market cap US$35.1m
12M price change -40.18%
Loading the 12-month Mave Thesis and 1-month news signal

Dashboard Funda..tals Prediction Screener Map

BIOLARGO, INC. Overview

Industry: Chemicals

Sector: Basic Materials

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. The company was incorporated in 1991 and is based in Westminster, California. BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic comp Read More

Mavefund brings filings, fundamentals, valuation, price history and news for BIOLARGO, INC. into one research view. The sections below show what strengthens or weakens the research case.

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 15, 2026

Quarterly result summary

Latest company-filed earnings material is available for source review.

What changed

  • Review the SEC source filing for the full reported results and management commentary.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

SEC filing Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Prediction-grade evidence

Recent News

Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

Earnings Per Share

Score 4.00/5
BIOLARGO, INC. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
In Chemicals industry , PPG Industries Inc , Dow Inc , AdvanSix are companies with high ratings.

Return on Equity

Score 0.30/5
BIOLARGO, INC. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
BIOLARGO, IN... BLGO US$35.1m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Net Margin

Score 0.40/5
BIOLARGO, INC. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Linde PLC NEWMARKET CORP Sherwin-Williams Co
BIOLARGO, IN... BLGO US$35.1m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Share Buyback

In Chemicals industry , PPG Industries Inc , Dow Inc , AdvanSix are companies with high ratings.

Leverage

Score 1.98/5
BIOLARGO, INC. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Linde PLC NEWMARKET CORP Sherwin-Williams Co have achieved high scores.
BIOLARGO, IN... BLGO US$35.1m
Linde PLC LIN US$246.2b
NEWMARKET CO... NEU US$7.0b
Sherwin-Will... SHW US$82.8b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Verified SEC statements load when this section enters view.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

BIOLARGO, INC. logo

BIOLARGO, INC.

US$0.11

US$35.1m

0.00%

-40.18%